Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Pandemic of Psychological Distress Is Upon Us

Tamar Rubinstein, MD, Natoshia Cunningham, PhD, & Andrea Knight, MD, MSCE  |  Issue: January 2021  |  January 20, 2021

Why Us?

For those questioning whether addressing mental health should fall within the realm of adult and pediatric rheumatologists, there are three things to consider. 

First, we have more access to our patients. Rheumatologists follow their patients more closely than primary care physicians. The difference in access to patients may be exaggerated during the pandemic. When patients with increased concerns of becoming infected are limiting their activities to what is perceived as the most urgent and essential, primary care visits are being deferred. This means, with the proper tools, rheumatologists are more likely to pick up mental health problems and more likely to find them earlier, when treatment can prevent suffering and downstream health effects. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Second, downstream health effects likely include effects on rheumatologic diseases, physical functioning, pain processing and other aspects of health we spend so much time and effort trying to improve.

Third, and most importantly, our patients demand it. Much of the behind-the-scenes efforts to understand and improve mental health for individuals with rheumatologic diseases is patient driven. Patients and families have been advocating long and hard for us to partner with them to help them overcome the mental health problems that so often come along with their diseases. This makes sense, considering how many view their rheumatology clinics as their medical homes, perhaps more so than their primary care clinics—a theme that permeates qualitative work done around mental health in pediatric rheumatology.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Do We Hear Them?

While the patient community is loud and clear, the question remains: Are rheumatologists listening? As rheumatologists, we have always faced depression and anxiety in our patients. The increased burden of mental health in the COVID era demands that we—collectively as a society and personally as healthcare providers—consider how we can address our patients’ mental health more effectively. 

Continuing our current practices will risk patients’ lives and well-being.


Tamar Rubinstein, MD, MS, MD, MSTamar Rubinstein, MD, MS, MD, MS, is an assistant professor of pediatric rheumatology at Children’s Hospital at Montefiore, The Bronx, N.Y. Her research focuses on improving mental health and SLE disease outcomes in youth. She is a co-leader of the CARRA Mental Health Workgroup.

Natoshia R. Cunningham, PhDNatoshia R. Cunningham, PhD, is a tenure-track assistant professor in the Department of Family Medicine at Michigan State University and a licensed clinical psychologist. She is leading a multi-site study funded by CARRA and the Arthritis Foundation to test a telehealth application of a tailored cognitive behavioral intervention for adolescents and young adults diagnosed with childhood-onset lupus to manage fatigue, mood and pain symptoms. Dr. Cunningham serves as the co-chair of CARRA’s Mental Health Workgroup.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsPatient Perspective Tagged with:COVID-19Mental Health

Related Articles

    The Future of Pediatric Rheumatology Grounded in Evolution of Childhood Arthritis and Rheumatology Research Alliance

    December 15, 2016

    Pediatric rheumatology was formally recognized as a specialty in 1991 by the American Board of Pediatrics. Prior to this time, children with rheumatic diseases were treated by a hodgepodge of providers. In addition to providers who had training as pediatric rheumatologists, general pediatricians, adult rheumatologists, allergist-immunologists, orthopedists, pediatric infectious disease specialists and others treated children…

    CARRA

    May 16, 2011

    Working for Children with Rheumatic Diseases

    Pediatric to Adult Care Transition Challenging for Patients with JIA

    Pediatric to Adult Care Transition Challenging for Patients with JIA

    May 15, 2015

    Dr. Sheffield is an adult rheumatologist who received the following referral request from a family doctor: “Please see this 22-year-old male with a history of juvenile arthritis for ongoing care. I have only seen him once, and have no previous medical records.” Dr. Sheffield meets with Paul, who reports that he has had arthritis since…

    MIA Studio / shutterstock.com

    ACR Releases COVID-19 & MIS-C Clinical Guidance for Kids with Rheumatic Disease

    August 12, 2020

    The ACR has released clinical guidance documents for pediatric patients with rheumatic disease in the context of the COVID-19 pandemic, including one for multi-system inflammatory syndrome in children (MIS-C). Jay Mehta, MD, MS, an attending physician in the Division of Rheumatology and director of the Pediatric Rheumatology Fellowship at the Children’s Hospital of Philadelphia (CHOP),…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences